Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Clinical Oncology

• Publication date

  2008-01-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2007.12.3927PMID 18182669
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anwendung

  2019cited by this paper
• Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial.

  2007cited by this paper
• Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

  2007cited by this paper
• Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia.

  2007cited by this paper
• Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 study.

  2005cited by this paper
• Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study.

  2005cited by this paper
• Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia.

  2005cited by this paper
• Outcome of very late relapse in children with acute lymphoblastic leukemia.

  2004cited by this paper
• Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone.

  2003cited by this paper
• Late relapse of childhood acute lymphoblastic leukemia and pcr-monitoring of minimal residual disease: how much time can elapse between "molecular" and clinical relapse?

  2002cited by this paper
• Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II.

  2002cited by this paper
• Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Acute Lymphoblastic Leukemia Studies, 1982–1995

  2000cited by this paper
• Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies.

  1998cited by this paper
• Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

  1998cited by this paper
• Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.

  1998cited by this paper
• Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X

  1997cited by this paper
• Clinical relevance of DNA ploidy and proliferative activity in childhood rhabdomyosarcoma: a retrospective analysis of patients enrolled onto the Italian Cooperative Rhabdomyosarcoma Study RMS88.

  1997cited by this paper
• Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.

  1995cited by this paper
• Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86.

  1994cited by this paper
• Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the "BFM Family" Cooperative Group.

  1992cited by this paper
• Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study.

  1992cited by this paper
• Near-haploidy in childhood leukemia: a high-risk component.

  1988cited by this paper
• Hypodiploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia.

  1987cited by this paper
• [Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)].

  1987cited by this paper
• Die Corticosteroid-abhängige Dezimierung der Leukämiezellzahl im Blut als Prognosefaktor bei der akuten lymphoblastischen Leukämie im Kindesalter (Therapiestudie ALL-BFM 83)

  1987cited by this paper
• [Estimation of tumor cell mass in childhood acute lymphoblastic leukemia: prognostic significance and practical application].

  1982cited by this paper
• Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group

  1976cited by this paper

• CD371+ pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.

  2024cites this paper
• Prognostic Role of CD200 in Acute Lymphoblastic Leukemia Patients

  2023cites this paper
• Prognostic and Pharmacotypic Heterogeneity of Hyperdiploidy in Childhood ALL

  2023cites this paper
• Default-Mode Network Connectivity Changes Correlate with Attention Deficits in ALL Long-Term Survivors Treated with Radio- and/or Chemotherapy

  2022cites this paper
• Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/KMT2A Rearrangements in a Modern Therapy Era: A Retrospective International Study

  2022cites this paper
• Re-Evaluate of DNA Index Among the Childhood Acute Lymphoblastic Leukemia

  2021cites this paper
• DNA index as prognostic factor in childhood acute lymphoblastic leukemia in the COG-TARGET database

  2021cites this paper
• Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial.

  2021cites this paper
• Clinical Characteristics and Treatment Results of Childhood Acute Lymphoblastic Leukemia in North Macedonia

  2020cites this paper
• Differing Outcomes of Patients with High Hyperdiploidy and ETV6-RUNX1 Rearrangement in Korean Pediatric Precursor B Cell Acute Lymphoblastic Leukemia

  2020cites this paper
• Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial

  2019cites this paper
• CLINICOHEMATOLOGICAL, IMMUNOPHENOTYPING, MOLECULAR PROFILE, AND OVERALL SURVIVAL IMPACT IN ACUTE LYMPHOID LEUKEMIA PATIENTS FROM NORTH INDIA

  2019cites this paper
• Cytogenetic Profile of Moroccan Pediatric Acute Lymphoblastic Leukemia: Analysis of 155 Cases With a Review of the Literature

  2018cites this paper
• Acute Lymphoid Leukaemias (ALL) and Minimal Residual Disease in ALL

  2018cites this paper
• Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology.

  2017cites this paper
• ALLIC-BFM 2002 protocol in the Institute of Hematology and Inmunology: ten years of experience

  2016cites this paper
• Comparison of Donor Sources in Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Nationwide Retrospective Study.

  2016cites this paper
• Treatment of acute lymphoblastic leukemia in children: a review of literature

  2016cites this paper
• Improved survival in adult patients with acute lymphoblastic leukemia in the Netherlands: a population-based study on treatment, trial participation and survival

  2016cites this paper
• High Frequency and Poor Prognosis of Late Childhood BCR-ABL-Positive and MLL-AF4-Positive ALL Define the Need for Advanced Molecular Diagnostics and Improved Therapeutic Strategies in Pediatric B-ALL in Pakistan

  2015cites this paper
• Improved outcome for children and adolescent with acute lymphoblastic leukemia in the first decade of the 21st century: A report from the Slovak Republic.

  2015cites this paper
• Leukemia blast cell identification

  2015cites this paper
• Prognostification of ALL by Cytogenetics

  2015cites this paper
• Impact of the Clinicolaboratory Characteristics on the Treatment Outcome of the Pediatric Patients with Acute Lymphoblastic Leukemia at South Egypt Cancer Institute

  2015cites this paper
• Acute lymphoblastic leukemia in children and adolescents: prognostic factors and analysis of survival

  2015cites this paper
• Increased post‐induction intensification improves outcome in children and adolescents with a markedly elevated white blood cell count (≥200 × 109/l) with T cell acute lymphoblastic leukaemia but not B cell disease: a report from the Children's Oncology Group

  2015cites this paper
• Minimal residual disease in acute lymphoblastic leukemia: optimal methods and clinical relevance, pitfalls and recent approaches

  2014cites this paper
• Acute Lymphoblastic Leukemia: Genetic Events and Molecular Signatures

  2014cites this paper
• An investigation into the role of receptor tyrosine kinases in childhood Acute Lymphoblastic Leukaemia

  2014cites this paper
• Raised Expression of APRIL in Chinese Children With Acute Lymphoblastic Leukemia and its Clinical Implications

  2014cites this paper
• Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study.

  2014cites this paper
• Near Infrared Spectroscopy (NIRS) as a New Non-Invasive Tool to Detect Oxidative Skeletal Muscle Impairment in Children Survived to Acute Lymphoblastic Leukaemia

  2014cites this paper
• Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002.

  2014cites this paper
• Cranial radiation for pediatric T‐lineage acute lymphoblastic leukemia: A systematic review and meta‐analysis

  2014cites this paper
• Improving treatment of children with acute lymphoblastic leukemia in developing countries through technology sharing, collaboration and partnerships

  2014cites this paper
• Expanding clinical trial networks in pediatric acute lymphoblastic leukemia.

  2014cites this paper
• Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL‐negative acute lymphoblastic leukemia

  2013cites this paper
• Enhanced levels of the apoptotic BAX/BCL-2 ratio in children with acute lymphoblastic leukemia and high-risk features

  2013influential citation
• Chapter 9 Role of Cytogenetic Analysis in the Diagnosis and Classification of Hematopoietic Neoplasms

  2013cites this paper
• The Principle and Practice of Reinduction Therapy (in ALL): REPETITA IUVANT!

  2013cites this paper
• Diagnosis and Treatment of Childhood Acute Lymphoblastic Leukemia

  2013cites this paper
• [Treatment of acute lymphoblastic leukemia in childhood: state of things and outlook for the future].

  2012cites this paper
• ALL-BFM 95 Treatment in Turkish Children with Acute Lymphoblastic Leukemia—Experience of a Single Center

  2012cites this paper
• Behandlung der akuten lymphoblastischen Leukämie im Kindesalter

  2012cites this paper
• Outcomes after induction failure in childhood acute lymphoblastic leukemia.

  2012cites this paper
• Implementation of an intensive risk‐stratified treatment protocol for children and adolescents with acute lymphoblastic leukemia in Lebanon

  2012cites this paper
• Acute lymphoblastic leukemia in children: treatment planning via minimal residual disease assessment.

  2012cites this paper
• The Role of HDACs Inhibitors in Childhood and Adolescence Acute Leukemias

  2011influential citation
• Autologous purified peripheral blood SCT in childhood low-risk relapsed ALL

  2011cites this paper
• Physical Activity and Late Effects in Childhood Acute Lymphoblastic Leukemia Long-Term Survivors

  2011cites this paper
• Acute Lymphoblastic Leukemia: Presentation, Diagnosis and Classification

  2011cites this paper
• Cytogenetic profile of pediatric acute lymphoblastic leukemia (ALL): analysis of 31 cases with review of literature

  2011cites this paper
• Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study.

  2010cites this paper
• leukemia : results in 3184 patients of the AIEOP-BFM ALL 2000 study children and adolescents with B-cell precursor acute lymphoblastic Molecular response to treatment redefines all prognostic factors in

  2010cites this paper
• Molecular characterization of paediatric idiopathic hypereosinophilia

  2010cites this paper
• Systematic review of the addition of vincristine plus steroid pulses in maintenance treatment for childhood acute lymphoblastic leukaemia – an individual patient data meta‐analysis involving 5659 children

  2010cites this paper
• Randomized trial to compare LSA2L2‐type maintenance therapy to daily 6‐mercaptopurine and weekly methotrexate with vincristine and dexamethasone pulse for children with acute lymphoblastic leukemia

  2010cites this paper
• CD9 expression can be used to predict childhood TEL/AML1-positive acute lymphoblastic leukemia: proposal for an accelerated diagnostic flowchart.

  2010cites this paper
• Long-term results of Tokyo Children's Cancer Study Group trials for childhood acute lymphoblastic leukemia, 1984–1999

  2010cites this paper
• Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution

  2010cites this paper
• DNA Index in childhood acute lymphoblastic leukaemia: a karyotypic method to validate the flow cytometric measurement

  2010cites this paper
• HOX gene expression in phenotypic and genotypic subgroups and low HOXA gene expression as an adverse prognostic factor in pediatric ALL

  2010cites this paper
• Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia

  2010cites this paper
• Genetic aberrations in paediatric acute leukaemias and implications for management of patients.

  2010cites this paper
• Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951.

  2010cites this paper
• Pediatric T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma therapy

  2009cites this paper
• Analysis of relapses in children with acute lymphoblastic leukaemia

  2009cites this paper
• Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: Role of polymorphisms of genes involved in glucocorticoid response

  2009cites this paper
• High-risk childhood acute lymphoblastic leukemia.

  2009cites this paper
• Treatment of childhood acute lymphoblastic leukemia.

  2009cites this paper
• Acute lymphoblastic leukemia and Down syndrome

  2008cites this paper
• Efficacy and safety of intrathecal liposomal cytarabine for the treatment of meningeal relapse in acute lymphoblastic leukemia: Experience of two pediatric institutions

  2008cites this paper
• Treatment of pediatric acute lymphoblastic leukemia

  2008cites this paper
• Clinical Trials and Observations

  year unknowncites this paper